MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Cardiovascular Systems Company Profile (NASDAQ:CSII)

Consensus Ratings for Cardiovascular Systems (NASDAQ:CSII) (?)
Ratings Breakdown: 2 Sell Rating(s), 1 Hold Rating(s), 5 Buy Rating(s)
Consensus Rating:Hold (Score: 2.38)
Consensus Price Target: $19.50 (139.26% upside)

Analysts' Ratings History for Cardiovascular Systems (NASDAQ:CSII)
Show:
DateFirmActionRatingPrice TargetActions
1/22/2016Leerink SwannReiterated RatingHold$17.00 -> $13.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/22/2016Needham & Company LLCDowngradeBuy -> UnderperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/23/2015Northcoast ResearchInitiated CoverageBuy$18.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/5/2015Needham & Company LLCBoost Price TargetBuy$18.00 -> $19.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/8/2015William BlairReiterated RatingOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/8/2015Feltl & Co.DowngradeStrong-Buy -> BuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/8/2015Dougherty & CoLower Price TargetBuy$50.00 -> $32.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/8/2015Benchmark Co.Lower Price TargetBuy$49.00 -> $20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/8/2015Bank of AmericaDowngradeNeutral -> Underperform$15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/8/2015Needham & Company LLCDowngradeStrong-Buy -> Buy$37.00 -> $18.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/8/2015Leerink SwannDowngradeOutperform -> Market Perform$45.00 -> $17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/6/2015Needham & Company LLCLower Price TargetStrong-Buy$45.00 -> $37.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/23/2015Leerink SwannReiterated RatingBuy$45.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/9/2015William BlairReiterated RatingOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/24/2015Leerink SwannSet Price TargetBuy$45.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/5/2015Leerink SwannReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/30/2015Needham & Company LLCReiterated RatingStrong-Buy$43.00 -> $45.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/7/2014Benchmark Co.Boost Price TargetBuy$38.00 -> $42.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/7/2014Needham & Company LLCBoost Price TargetStrong-Buy$37.00 -> $38.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/12/2014Bank of AmericaInitiated CoverageBuy$38.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/1/2014Needham & Company LLCLower Price TargetStrong-Buy$47.00 -> $37.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/21/2014Needham & Company LLCInitiated CoverageStrong-Buy$47.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 2/13/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by the American Association of Individual Investors As Featured by Seeking Alpha